Results 191 to 200 of about 3,293,378 (262)

Comparison of Serious Adverse Event Profiles Among Antirheumatic Agents Using Japanese Adverse Drug Event Report Database

Therapeutic Innovation and Regulatory Science, 2018
Yomei Matsuoka, M. Narukawa
semanticscholar   +1 more source

[Immunomodulation by symptomaticly active antirheumatic agents].

Immunitat und Infektion, 1985
As antigen-presenting and/or monokine-secreting cells, macrophages play a major role in immunoregulation. Proteases of macrophage origin (cathepsin G, elestase, thrypsin and pronase) act on cell surfaces of different cell lines, inducing cell activation, e.g. of B-lymphocytes. T-lymphocytes might be stimulated by the activating factor LAF.
R, Dreher, K, Fink, H, Seidel, P, Wagner, B, Rohrbach, K, Federlin   +5 more
openaire   +1 more source

Cardiovascular Risk Profile of Antirheumatic Agents in Patients with Osteoarthritis and Rheumatoid Arthritis

Drugs, 2012
M. Nurmohamed, V. P. Halm, B. Dijkmans
semanticscholar   +1 more source

Safe use of antirheumatic agents in patients with comorbidities.

Rheumatic Disease Clinics of North America, 2012
A. Makol, K. Wright, E. Matteson
semanticscholar   +1 more source

Studies on type II collagen-induced polyarthritis in rats. Effect of antiinflammatory and antirheumatic agents.

Arthritis & Rheumatism, 1981
A. Sloboda, J. Birnbaum, A. Oronsky, S. Kerwar   +3 more
semanticscholar   +1 more source

[Immunomodulation with symptomatically effective antirheumatic agents].

Immunitat und Infektion, 1984
As antigen-presenting and/or monokine-secreting cells, macrophages play a major role in immunoregulation. Proteases of macrophage origin (cathepsin G, elestase , thrypsin and pronase) act on cell surfaces of different cell lines, inducing cell activation, e.g. of B-lymphocytes. T-lymphocytes might be stimulated by the activating factor LAF.
R, Dreher, K, Fink, H, Seidel, P, Wagner, B, Rohrbach, K, Federlin   +5 more
openaire   +1 more source

Relationships between knowledge and experience in the use of disease-modifying antirheumatic agents. A study of primary care practitioners.

Journal of the American Medical Association (JAMA), 1989
J. Stross
semanticscholar   +1 more source

Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysis

Annals of the Rheumatic Diseases, 2010
Carine Salliot, A. Finckh, W. Katchamart, Yan Lu, Ye Sun, C. Bombardier, E. Keystone   +6 more
semanticscholar   +1 more source

Molecular imaging in oncology: Current impact and future directions

Ca-A Cancer Journal for Clinicians, 2022
Steven P Rowe, Martin G Pomper
exaly  

The antirheumatic agents sulphasalazine and methotrexate share an anti-inflammatory mechanism.

British Journal of Rheumatology, 1995
B. Cronstein
semanticscholar   +1 more source